These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1446 related items for PubMed ID: 15350319

  • 21. Comparison of the ocular hypotensive effects of bimatoprost and timolol-dorzolamide combination in patients with elevated intraocular pressure: a 6-month study.
    Ozturk F, Ermis SS, Inan UU.
    Acta Ophthalmol Scand; 2007 Feb; 85(1):80-3. PubMed ID: 17244215
    [Abstract] [Full Text] [Related]

  • 22. Effect of bimatoprost on intraocular pressure after phacoemulsification in eyes with exfoliation syndrome.
    Takmaz T, Can I, Gürdal C, Kürkçüoğlu P, Aşik S.
    Acta Ophthalmol Scand; 2007 May; 85(3):262-6. PubMed ID: 17488454
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Cost-effectiveness of monotherapy treatment of glaucoma and ocular hypertension with the lipid class of medications.
    Noecker RJ, Walt JG.
    Am J Ophthalmol; 2006 Jan; 141(1 Suppl):S15-21. PubMed ID: 16389056
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Feasibility and efficacy of a mass switch from latanoprost to bimatoprost in glaucoma patients in a prepaid Health Maintenance Organization.
    Law SK, Song BJ, Fang E, Caprioli J.
    Ophthalmology; 2005 Dec; 112(12):2123-30. PubMed ID: 16225924
    [Abstract] [Full Text] [Related]

  • 27. Ocular effects of topical 0.03% bimatoprost solution in normotensive feline eyes.
    Regnier A, Lemagne C, Ponchet A, Cazalot G, Concordet D, Gelatt KN.
    Vet Ophthalmol; 2006 Dec; 9(1):39-43. PubMed ID: 16409244
    [Abstract] [Full Text] [Related]

  • 28. [Aqueous humor flow measured by fluorophotometry. A comparative study of the effect of various beta-blocker eyedrops in patients with ocular hypertension].
    Coulangeon LM, Sole M, Menerath JM, Sole P.
    Ophtalmologie; 1990 Dec; 4(2):156-61. PubMed ID: 2235007
    [Abstract] [Full Text] [Related]

  • 29. A multicentre evaluation of the effect of patient education on acceptance of hyperaemia associated with bimatoprost therapy for glaucoma or ocular hypertension.
    Trattler W, Noecker RJ, Earl ML.
    Adv Ther; 2008 Mar; 25(3):179-89. PubMed ID: 18351298
    [Abstract] [Full Text] [Related]

  • 30. Efficacy and safety of bimatoprost as replacement for latanoprost in patients with glaucoma or ocular hypertension: a uniocular switch study.
    Casson RJ, Liu L, Graham SL, Morgan WH, Grigg JR, Galanopoulos A, Crawford A, House PH.
    J Glaucoma; 2009 Mar; 18(8):582-8. PubMed ID: 19826386
    [Abstract] [Full Text] [Related]

  • 31. Intraocular pressure elevation within the first 24 hours after cataract surgery in patients with glaucoma or exfoliation syndrome.
    Levkovitch-Verbin H, Habot-Wilner Z, Burla N, Melamed S, Goldenfeld M, Bar-Sela SM, Sachs D.
    Ophthalmology; 2008 Jan; 115(1):104-8. PubMed ID: 17561259
    [Abstract] [Full Text] [Related]

  • 32. A comparison of long-term intraocular pressure fluctuation in patients treated with bimatoprost or latanoprost.
    Simmons ST, Bernstein P, Hollander DA.
    Am J Ophthalmol; 2008 Sep; 146(3):473-7. PubMed ID: 18561893
    [Abstract] [Full Text] [Related]

  • 33. Flare-up rates with bimatoprost therapy in uveitic glaucoma.
    Fortuna E, Cervantes-Castañeda RA, Bhat P, Doctor P, Foster CS.
    Am J Ophthalmol; 2008 Dec; 146(6):876-82. PubMed ID: 19027422
    [Abstract] [Full Text] [Related]

  • 34. Diurnal and nocturnal variations in aqueous humor dynamics of patients with ocular hypertension undergoing medical therapy.
    Gulati V, Fan S, Zhao M, Maslonka MA, Gangahar C, Toris CB.
    Arch Ophthalmol; 2012 Jun; 130(6):677-84. PubMed ID: 22332206
    [Abstract] [Full Text] [Related]

  • 35. A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
    Franks WA, Renard JP, Cunliffe IA, Rojanapongpun P.
    Clin Ther; 2006 Mar; 28(3):332-9. PubMed ID: 16750448
    [Abstract] [Full Text] [Related]

  • 36. Inter-visit intraocular pressure range: an alternative parameter for assessing intraocular pressure control in clinical trials.
    Varma R, Hwang LJ, Grunden JW, Bean GW.
    Am J Ophthalmol; 2008 Feb; 145(2):336-42. PubMed ID: 18222194
    [Abstract] [Full Text] [Related]

  • 37. Efficacy and safety of a fixed combination of travoprost 0.004%/timolol 0.5% ophthalmic solution once daily for open-angle glaucoma or ocular hypertension.
    Schuman JS, Katz GJ, Lewis RA, Henry JC, Mallick S, Wells DT, Sullivan EK, Landry TA, Bergamini MV, Robertson SM.
    Am J Ophthalmol; 2005 Aug; 140(2):242-50. PubMed ID: 16086946
    [Abstract] [Full Text] [Related]

  • 38. Aqueous humor concentrations of bimatoprost free acid, bimatoprost and travoprost free acid in cataract surgical patients administered multiple topical ocular doses of LUMIGAN or TRAVATAN.
    Faulkner R, Sharif NA, Orr S, Sall K, Dubiner H, Whitson JT, Moster M, Craven ER, Curtis M, Pailliotet C, Martens K, Dahlin D.
    J Ocul Pharmacol Ther; 2010 Apr; 26(2):147-56. PubMed ID: 20307216
    [Abstract] [Full Text] [Related]

  • 39. Bimatoprost 0.03% preservative-free ophthalmic solution versus bimatoprost 0.03% ophthalmic solution (Lumigan) for glaucoma or ocular hypertension: a 12-week, randomised, double-masked trial.
    Day DG, Walters TR, Schwartz GF, Mundorf TK, Liu C, Schiffman RM, Bejanian M.
    Br J Ophthalmol; 2013 Aug; 97(8):989-93. PubMed ID: 23743437
    [Abstract] [Full Text] [Related]

  • 40. Effects of Topical Bimatoprost 0.01% and Timolol 0.5% on Circadian IOP, Blood Pressure and Perfusion Pressure in Patients with Glaucoma or Ocular Hypertension: A Randomized, Double Masked, Placebo-Controlled Clinical Trial.
    Oddone F, Rossetti L, Tanga L, Berardo F, Ferrazza M, Michelessi M, Roberti G, Manni G, Centofanti M.
    PLoS One; 2015 Aug; 10(10):e0140601. PubMed ID: 26484767
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 73.